MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

An investigation of Parkinson’s disease patients’ desired control over the DBS stimulator

C.S. Kubu, J. Vitek, S.E. Cooper, A. Machado, P.J. Ford (Cleveland, OH, USA)

Meeting: 2016 International Congress

Abstract Number: 64

Keywords: Deep brain stimulation (DBS), Parkinsonism

Session Information

Date: Monday, June 20, 2016

Session Title: Surgical Therapy

Session Time: 12:30pm-2:00pm

Objective: To understand changes in patients’ desired control of the DBS stimulator in a consecutive series of subjects who underwent DBS for the treatment of PD.

Background: PD candidates for DBS often describe their motivation to seek out surgery in language that implies the desire to regain control over their bodies (e.g., reduce tremor, minimize motor fluctuations). Yet, in order to achieve greater control over their lives, DBS patients relinquish control over their bodies to the physician who adjusts the stimulator. We investigated subjects’ ratings of desired control of the stimulator prior to and after DBS and the relationship between those ratings to self-perceived global control.

Methods: A consecutive series of 52 patients with PD completed visual analog scales (VAS) in which subjects rated their desired control over the stimulator (10 representing greatest control) prior to DBS surgery. Subjects also rated their sense of global control on a VAS. The ratings were re-administered at 3 and 6 months post-surgery. Repeated measures ANOVAs were used to examine changes over time. The relationship between the control ratings over time was assessed using Pearson correlations.

Results: Most subjects were men (75%) with a mean age of 61.3 yrs. Subjects reported a significant improvement in their self ratings of global control (F(1,44)=13.9, p<.01) as a result of DBS (Baseline=6.7+/-2.7, Month 3=7.9+/- 2.2, Month 6=8.2 +/-1.7). In contrast, subjects’ desired control of the stimulator declined significantly over time (F(1,42)=11.8, p<.01; Baseline=6.2+/-3.5, Month 3= 4.9+/-3.9, Month 6=3.9+/-3.5). Changes in subjects’ perceptions of global control were significantly negatively correlated with changes in their desired stimulator control (r=-.31, p<0.05).

Conclusions: Patients with PD reported a significant decrease in their desire to control the stimulator over the course of DBS treatment that was significantly correlated with increases in their sense of global control over their lives in general. This is the first report, to our knowledge, that systematically assessed PD patients’ desire for stimulator control over the course of DBS. These initial findings have implications with respect to the development of patient controlled stimulator devices and suggest that relinquishing some aspects of control does not correspond to a similar loss of global control over one’s life in the context of DBS.

To cite this abstract in AMA style:

C.S. Kubu, J. Vitek, S.E. Cooper, A. Machado, P.J. Ford. An investigation of Parkinson’s disease patients’ desired control over the DBS stimulator [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/an-investigation-of-parkinsons-disease-patients-desired-control-over-the-dbs-stimulator/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/an-investigation-of-parkinsons-disease-patients-desired-control-over-the-dbs-stimulator/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley